Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.7500 (2.58%) ($8.5600 - $8.7500) on Tue. May. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.61% (three month average) | RSI | 61 | Latest Price | $8.7500(2.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(28%) XLRE(27%) BND(25%) CEMB(25%) SDY(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.305% in a week (0% probabilities). VIXM(-25%) VXX(-24%) TLT(-15%) VCIT(-12%) LQD(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.305% (StdDev 2.61%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.52(2.7%) | 10 Day Moving Average | $8.52(2.7%) | 20 Day Moving Average | $8.28(5.68%) | To recent high | -7.4% | To recent low | 18.6% | Market Cap | $1.544b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |